TWO DAYS after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access.
This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.
FDA just completed the largest-ever testing of infant formula testing (covering 300 products), part of our broader approach to deliver for American families.
🍼 Rigorous testing and oversight
🍼 Re-evaluating nutrient requirements to allow for more innovative products
🍼 Building more secure supply chain
A milestone day for clinical trial innovation.
We’re announcing the first real-time clinical trials, where @fda can see data signals and endpoints in real time. A quick explainer:
